Health

In a major public health boost, Gaza has received a shipment of polio vaccines aimed at protecting more than 640,000 children from the virus, marking the first such effort in 25 years due to a recently reported case. The United Nations, along with Israeli and Gaza health officials, are coordinating this critical initiative. The campaign, led by UNICEF and supported by the World Health Organization and UNRWA, includes the distribution of 1.2 million doses of polio vaccine. The Ministry of Health in Gaza has confirmed the arrival of the vaccines and is preparing for a large-scale vaccination campaign targeting children…

In recent news, the White House has made a significant announcement that marks a new chapter in health care policy. This development is the culmination of years of tireless effort: For the first time, the U.S. government has successfully negotiated drug prices directly with pharmaceutical companies. This achievement is noteworthy because the battle to reduce health care costs has always been daunting; thus, Medicare’s new ability to negotiate marks a pivotal moment. In the United States, an estimated 18 million people struggle to afford essential medications. As a result, any reduction in drug prices is likely to have a substantial…

The Food and Drug Administration (FDA) on Thursday greenlit a new round of annual COVID-19 vaccines, clearing the way for Americans of all ages to receive updated protection against the current summer surge. Vaccine giants Pfizer and Moderna will begin distributing doses to health care workers within days. These vaccines target the dominant variant that emerged this spring, although newer, more closely related strains are now circulating. All of these variants appear to be more transmissible than previous ones. The new boosters offer a critical lifeline for vulnerable populations, especially older adults, who have borne the brunt of COVID-related deaths…

In the realm of medical advances, a significant breakthrough has emerged with the introduction of Neffy, a nasal spray that has received approval from the Food and Drug Administration. This innovative device stands out as the pioneering needle-free option for managing severe allergic reactions, offering significant relief to those with a deep fear of the injections typically associated with emergency treatments like the EpiPen. Dr. Michael Blaiss, a respected allergist at the Medical College of Georgia, highlights a common scenario in his practice: Patients are often reluctant to use traditional autoinjectors during allergy emergencies. Their apprehension is so great that…

MultiPlan, a key player in the health insurance industry credited with helping major insurers save billions through minimized medical reimbursements, is currently going through a tumultuous period of increased regulatory and financial scrutiny. The New York-based company, which influences more than 100,000 health plans covering more than 60 million people, has come under fire for practices that could leave patients with large medical bills. Recent investigations have shed a harsh light on MultiPlan’s marketing tactics, which often result in insurers paying health care providers significantly less than they are charged. This strategy, while financially advantageous for insurers and MultiPlan, often…

The World Health Organization (WHO) has stepped up its response to the mpox outbreak by declaring it a global health emergency. The declaration came on Wednesday, marking the second such declaration in the past three years as the virus rapidly spreads to multiple African nations. Currently, the Democratic Republic of the Congo is experiencing the most severe impact of the outbreak, with a reported count of 15,600 cases and 537 deaths. The current outbreak has surpassed the severity of the 2022 episode, during which a similar emergency was declared. Mpox, formerly known as monkeypox, was renamed in 2022 following concerns…

Three research papers exploring MDMA-assisted therapy for PTSD have been retracted by the journal Psychopharmacology. This follows the recent rejection of MDMA for this use by the Food and Drug Administration (FDA). The retracted studies, written by researchers affiliated with Lykos Therapeutics, the company behind the rejected treatment application, were found to involve unethical conduct at one of the research sites. Lykos, however, maintains that the retracted research was not part of their submission to the FDA. This development adds another layer of complexity to the ongoing debate over MDMA-assisted therapy. While some research suggests its potential in treating PTSD,…

A recent pilot study found that drinking a beverage containing erythritol (an artificial sweetener used to boost the content of stevia and monk fruit and to sweeten low-carb ketogenic products) more than doubled the risk of blood clots in 10 healthy individuals. Blood clots can break off from blood vessels and travel to the heart, triggering a heart attack, or the brain, causing a stroke. Previous research has linked erythritol to an increased risk of stroke, heart attack, and death. Dr. Stanley Hazen, lead author of the study and director of the Cardiovascular Diagnostic and Prevention Center at the Cleveland…

Early detection of cancer is critical to saving lives and mitigating the financial burden associated with treating this disease, health officials say. Understanding the mechanisms underlying this diagnosis becomes increasingly crucial as the incidence of cancer shifts to younger age groups, as highlighted in a report released in January by the American Cancer Society. The report, published in CA: A Cancer Journal for Clinicians, reveals a troubling trend: While the general population in the United States is aging, individuals under age 50 are experiencing an increase in overall cancer incidence from 1995 to 2020. This contrasts with older age groups,…

In a groundbreaking initiative, infants with peanut allergies across Australian hospitals will now have access to a life-changing treatment program aimed at building tolerance to this common allergy. The pioneering program, the first of its kind in the world, is a collaboration between the National Centre of Excellence in Allergy (NACE) and the Murdoch Children's Research Institute (MCRI). Known as the ADAPT OIT Program, it is tailored for infants under 12 months who have been diagnosed with a peanut allergy and are under the care of allergy specialists at ten children’s hospitals in five states in Australia. The treatment, provided…